New drug duo tested for Tough-to-Treat lung cancer
NCT ID NCT05001971
Summary
This study tested whether combining two drugs, anlotinib and penpulimab, could help control small cell lung cancer in patients whose initial platinum-based chemotherapy stopped working. The goal was to see if this combination could slow cancer growth and help patients live longer. The trial involved 65 participants in China who received both drugs in repeating cycles.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nong Yang
Changsha, Hunan, 410000, China
Conditions
Explore the condition pages connected to this study.